Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Ocular Drug Delivery Market Size Changed, over the years?
In recent years, the market for ocular drug delivery has significantly increased, with projections showing it will escalate from $18.14 billion in 2024 to $19.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historic period is linked to an increase in eye diseases, the demographic trend of an aging population, progress in pharmaceutical formulations, advancements in ophthalmology, and a higher rate of diabetes-related eye conditions.
How Much Will the Ocular Drug Delivery Market Be Worth in 2029?
Expectations are high for strong expansions in the ocular drug delivery market in the upcoming years, with projections suggesting it could increase to a value of $27.18 billion by 2029. This growth, calculated at a compound annual growth rate (CAGR) of 8.9%, can be linked to a number of factors such as the increased rates of eye conditions connected to aging, the emerging focus on personalized medicine within the field of ophthalmology, higher levels of funding for research into ophthalmic treatments, a growing demand for long-lasting drug release, and worldwide efforts to improve eye health. Over this forecast period, it’s anticipated that important trends will emerge, such as the creation of smart devices for administering drugs, the personalization of ocular drug formulations, advancement in topical ophthalmic therapies, and cross-sector collaborations for the sake of developing innovative solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11901&type=smp
Which is the Largest Company in the Ocular Drug Delivery Market?
Major companies operating in the ocular drug delivery market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Spark Therapeutics Inc., Carl Zeiss Meditec AG, EyeGate Pharmaceuticals Inc.
What Are the Main Market Drivers in the Ocular Drug Delivery Industry?
The anticipated rise in ocular conditions is forecasted to stimulate the expansion of the ocular drug delivery market. The term “eye disorders” encompasses a broad spectrum of illnesses that impact the eyes, visibility, and the surrounding structures. With ocular drug delivery, medication is directly delivered to the desired site, which increases drug concentration at the targeted region, heightens therapeutic effectiveness, mitigates systemic side effects, and enhances ocular health. For instance, the World Health Organization, a United Nations agency headquartered in Switzerland, projected in March 2023 that globally, around 2.2 billion individuals will suffer from myopia or hypermetropia. As per the calculations, the leading causes of vision loss or impaired vision are cataracts (94 million) and uncorrected refractive errors (88.4 million). Other common vision impairment causes include glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases), and trachoma (2 million cases). As a result, the rising prevalence of ocular disorders is accelerating the growth of the ocular drug delivery market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=11901&type=smp
How Is the Ocular Drug Delivery Market Segments Structured?
The ocular drug delivery market covered in this report is segmented –
1) By Technology: Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies
2) By Formulation: Liposomes And Nanoparticles, Solution, Emulsion, Suspension, Ointment
3) By Disease: Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, Other Diseases
4) By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Implantable Ocular Drug Delivery Systems: Intravitreal Implants, Subconjunctival Implants, Retrobulbar Implants
2) By Particulate Drug Delivery Systems: Microparticles, Liposomes, Microspheres
3) By Nano-Particle Drug Delivery Systems: Nanoemulsions, Nanoparticles For Sustained Release, Dendrimers
4) By Other Technologies: Hydrogels, Contact Lenses With Drug Delivery, In situ Gel-Forming Systems
What Strategic Trends Are Transforming the Ocular Drug Delivery Market?
Product enhancement is an emerging trend catching on in the ocular drug delivery sector. Firms in this sector are concentrating on creating novel product innovations to maintain their market standing. For example, in March 2023, Alcon AG, a Swiss company specializing in eye care pharmaceuticals and medical devices, introduced TOTAL30 for astigmatism and SYSTANE HYDRATION for dry eye and ocular wellness. TOTAL30 is the pioneer and sole Toric lens incorporating water Gradient and Celligent Technology, enabling the lens to reflect the structure of the ocular surface and deliver outstanding performance in areas such as comfort, stability, and visual clarity. SYSTANE HYDRATION PF is an eye drop designed for ocular health that employs HydroBoost technology to replenish moisture, avert irritation, and bring relief from dry eye symptoms.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/ocular-drug-delivery-global-market-report
Which Global Regions Offer the Highest Growth in the Ocular Drug Delivery Market?
North America was the largest region in the ocular drug delivery market in 2024. The regions covered in the ocular drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11901
This Report Delivers Insight On:
1. How big is the ocular drug delivery market, and how is it changing globally?
2. Who are the major companies in the ocular drug delivery market, and how are they performing?
3. What are the key opportunities and risks in the ocular drug delivery market right now?
4. Which products or customer segments are growing the most in the ocular drug delivery market?
5. What factors are helping or slowing down the growth of the ocular drug delivery market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
